Cited by 628TGF-β signaling in diseasesCancer Cells and MetastasisKruppel-like factors research

The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.

TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

Open access

Cui, Wei, Fowlis, Deborah J, Bryson, Sheila, Duffie, Elizabeth, Ireland, Hazel, Balmain, Allan, Akhurst, Rosemary J·1996·Cell

DOI 10.1016/s0092-8674(00)80127-0

Open this paper in CoChat — free account Open PDF

Abstract

TGFbeta1 has been implicated in cell cycle control and carcinogenesis. To address the exact function of TGFbeta1 in skin carcinogenesis in vivo, mice with TGFbeta1 expression targeted to keratinocytes were subjected to long-term chemical carcinogenesis treatment. TGFbeta1 showed biphasic action during multistage skin carcinogenesis, acting early as a tumor suppressor but later enhancing the malignant phenotype. The transgenics were more resistant to induction of benign skin tumors than controls, but the malignant conversion rate was vastly increased. There was also a higher incidence of spindle cell carcinomas, which expressed high levels of endogenous TGFbeta3, suggesting that TGFbeta1 elicits an epithelial-mesenchymal transition in vivo and that TGFbeta3 might be involved in maintenance of the spindle cell phenotype. The action of TGFbeta1 in enhancing malignant progression may mimic its proposed function in modulating epithelial cell plasticity during embryonic development.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)80127-0

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2021 · Cited by 939
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early xenopus embryo
Kimelman, D., & Kirschner, M. W. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 872
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3210-0_8 · Cited by 869
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 744
In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological states
Ansari, B., Coates, P. J., Greenstein, B., & Hall, P. A. (1993) · The Journal of Pathology · doi:10.1002/path.1711700102 · Cited by 578

Show all 98 references

Research works printed but not linked: 11

Arteaga, 1990, Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies, Cell Growth Differ., 1, 367
Caulin, 1995, Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype, Cell Growth Differ., 6, 1027
Cui, W., and Akhurst, R.J. (1996). Transforming growth factors β: biochemistry and biology in vitro and in vivo. In Growth Factors and Cytokines in Health and Disease, C. Bondy and D. LeRoith, eds. (Greenwich, Connecticut: JAI Press), in press.
Cui, 1994, Lack of TGFβ1 expression in benign skin tumours of p53 null mice is prognostic for a high risk of malignant conversion, Cancer Res., 54, 5831
Dlugosz, 1995, Autocrine transforming growth factor α is dispensible for v-ras-Ha-induced epidermal neoplasia, Cancer Res., 55, 1883
Fowlis, 1992, Discordant TGFβ1 RNA and protein localisations during chemical carcinogenesis of the skin, Cell Growth Differ., 3, 81
Fowlis, 1996, Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter, Cell Growth Differ., 7, 679
Gomella, 1989, Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma, Cancer Res., 49, 6972
Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β), Oncogene, 6, 1471
Steiner, 1992, Transforming growth factor-β-1 overproduction in prostate cancer, Mol. Endocrinol., 6, 15
Tennenbaum, 1992, Extracellular matrix receptors and mouse skin carcinogenesis, Cancer Res., 52, 2966

Sorted by citations

Items 101–200 of 623

Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA
Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6628 · Cited by 196
The latent transforming growth factor β binding protein (LTBP) family
Öklü, R., & Hesketh, R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520601 · Cited by 189
Transforming growth factor-β signal transduction in epithelial cells
Yue, J., & Mulder, K. M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00143-7 · Cited by 196
The Discovery and Early Days of TGF-β: A Historical PerspectivePreprint
Moses, H. L., Roberts, A. B., & Derynck, R. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021865 · Cited by 198
SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · PubMed · Cited by 192
Transforming growth factor-β in breast cancer: too much, too late
Barcellos‐Hoff, M. H., & Akhurst, R. J. (2009) · Breast Cancer Research · doi:10.1186/bcr2224 · Cited by 193
Self-citation
TGF-beta Signaling in Cancer Treatment
Fabregat, I., Fernando, J., Mainez, J., & Sancho, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990591 · Cited by 187
CD44 is the Principal Mediator of Hyaluronic-Acid-Induced Melanoma Cell Proliferation
Assmann, V., Fieber, C., Herrlich, P., Hofmann‐Apitius, M., Termeer, C., Ahrens, T., & Simon, J. C. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.00236.x · Cited by 186
Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness
Gotzmann, J., Huber, H., Thallinger, C., Wolschek, M. F., Jansen, B., Schulte‐Hermann, R., Beug, H., & Mikulits, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1189 · Cited by 184
Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK
Voorneveld, P. W., Kodach, L. L., Jacobs, R. J., Liv, N., Zonnevylle, A. C., Hoogenboom, J. P., Biemond, I., Verspaget, H. W., Hommes, D. W., de Rooij, K. E., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.052 · Cited by 183
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
Dodagatta-Marri, E., Meyer, D. S., Reeves, M. Q., Paniagua, R., To, M. D., Binnewies, M., Broz, M. L., Mori, H., Wu, D., Adoumie, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0493-9 · Cited by 177
Self-citation
Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta
Teicher, B. A. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013177011767 · Cited by 177
SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X., & Rich, J. N. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.737.3.6 · Cited by 177
TGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 187
Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies
Tan, S., Khumalo, N. P., & Bayat, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01810 · Cited by 176
Epidermal growth factor signaling via Ras controls the Smad transcriptional co‐repressor TGIF
Lo, R. S., Wotton, D., & Massagué, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.128 · Cited by 171
Glioblastoma multiforme: a review of therapeutic targets
Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Bortoff, K., Bigner, D. D., Yan, H., & Adamson, D. C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902942348 · Cited by 174
Ultraviolet Irradiation Alters Transforming Growth Factor β/Smad Pathway in Human Skin In Vivo
Quan, T., He, T., Kang, S., Voorhees, J. J., & Fisher, G. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01834.x · Cited by 169
Transduction of a Mesenchyme-specific Gene Periostin into 293T Cells Induces Cell Invasive Activity through Epithelial-Mesenchymal Transformation
Yan, W., & Shao, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601856200 · Cited by 169
Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.937s.11.2 · Cited by 169
Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice
Bonyadi, M., Rusholme, S. A. B., Cousins, F. M., Su, H. C., Biron, C. A., Farrall, M., & Akhurst, R. J. (1997) · Nature Genetics · doi:10.1038/ng0297-207 · Cited by 166
Self-citation
Impaired prostate tumorigenesis in Egr1-deficient mice
Abdulkadir, S. A., Qu, Z., Garabedian, E. M., Song, S., Peters, T. J., Svaren, J. P., Carbone, J. M., Naughton, C. K., Catàlona, W. J., Ackerman, J. J. H., et al. (2001) · Nature Medicine · doi:10.1038/83231 · Cited by 162
Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase
Oloumi, A., McPhee, T. R., & Dedhar, S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.12.002 · Cited by 162
Ionizing Radiation Predisposes Nonmalignant Human Mammary Epithelial Cells to Undergo Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition
Andarawewa, K. L., Erickson, A., Chou, W. S., Costes, S. V., Gascard, P. D., Mott, J. D., Bissell, M. J., & Barcellos‐Hoff, M. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1294 · Cited by 162
Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary Tumors
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos‐Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 163
Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-β
Dumont, N., & Arteaga, C. L. (2000) · Breast Cancer Research · doi:10.1186/bcr44 · Cited by 158
Role of Type 2C Protein Phosphatases in Growth Regulation and in Cellular Stress Signaling
Lammers, T., & Lavi, S. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701693342 · Cited by 165
Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor β-induced Cell Motility
Ueda, Y., Wang, S., Dumont, N., Yi, J. Y., Koh, Y., & Arteaga, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400081200 · Cited by 157
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1
Goudie, D. R., D’Alessandro, M., Merriman, B., Lee, H., Szeverényi, I., Avery, S., O’Connor, B. D., Nelson, S. F., Coats, S. E., Stewart, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.780 · Cited by 157
Galectin-7, a marker of all types of stratified epithelia
Magnaldo, T., Fowlis, D. J., & Darmon, M. Y. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6330159.x · Cited by 157
Self-citation
Latent Transforming Growth Factor-β Activation in Mammary Gland
Ewan, K., Shyamala, G., Ravani, S. A., Tang, Y., Akhurst, R. J., Wakefield, L. M., & Barcellos‐Hoff, M. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61158-3 · Cited by 160
Self-citation
The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation
Burdick, A. D., Kim, D. J., Peraza, M. A., Gonzalez, F. J., & Peters, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.009 · Cited by 156
From transforming growth factor-β signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
Kang, H., Lin, H., Hu, Y., Yeh, S., Huang, K., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061305498 · Cited by 154
Radiation Acts on the Microenvironment to Affect Breast Carcinogenesis by Distinct Mechanisms that Decrease Cancer Latency and Affect Tumor Type
Nguyen, D. H. A., Oketch‐Rabah, H. A., Illa-Bochaca, I., Geyer, F. C., Reis-Filho, J. S., Mao, J., Ravani, S. A., Zavadil, J., Borowsky, A. D., Jerry, D. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.011 · Cited by 154
The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
Mishra, L., Shetty, K., Tang, Y., Stuart, A., & Byers, S. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208924 · Cited by 148
Glioblastoma Multiforme Oncogenomics and Signaling Pathways
Kanu, O. O., Hughes, B. D., Di, C., Lin, N., Fu, J., Bigner, D. D., Yan, H., & Adamson, C. (2009) · Clinical medicine Oncology · doi:10.4137/cmo.s1008 · Cited by 146
TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., & Gress, T. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1330 · Cited by 146
Epithelial–Mesenchymal Transition in Development and Cancer
Micalizzi, D. S., & Ford, H. L. (2009) · Future Oncology · doi:10.2217/fon.09.94 · Cited by 145
Multistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 144
Smad4-mediated TGF-β signaling in tumorigenesis
Yang, G., & Yang, X. Y. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.1 · Cited by 142
A delicate balance: TGF‐β and the tumor microenvironment
Stover, D. G., Bierie, B., & Moses, H. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21149 · Cited by 142
Signal Processing in the TGF-β Superfamily Ligand-Receptor Network
Vilar, J. M. G., Jansen, R., & Sander, C. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020003 · Cited by 142
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
Metelli, A., Wu, B. X., Riesenberg, B., Guglietta, S., Huck, J. D., Mills, C., Li, A., Rachidi, S., Krieg, C., Rubinstein, M. P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay4860 · Cited by 139
Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-β1-induced Pericellular Collagenolysis
Munshi, H. G., Wu, Y., Mukhopadhyay, S., Ottaviano, A. J., Sassano, A., Koblinski, J. E., Platanias, L. C., & Stack, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404958200 · Cited by 136
The role of Fas ligand and transforming growth factor β in tumor progression
Kim, R., Emi, M., Tanabe, K., Uchida, Y., & Toge, T. (2004) · Cancer · doi:10.1002/cncr.20270 · Cited by 140
Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
Odero‐Marah, V., Wang, R., Chu, G. C., Zayzafoon, M., Xu, J., Shi, C., Marshall, F. F., Zhau, H. E., & Chung, L. W. K. (2008) · Cell Research · doi:10.1038/cr.2008.84 · Cited by 138
Molecular Mechanisms of Mouse Skin Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Cancers · doi:10.3390/cancers2020436 · Cited by 140
Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression
Lefort, K., & Dotto, G. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.017 · Cited by 135
Photopheresis: Clinical Applications and Mechanism of Action
Rook, A. H., Suchin, K. R., Kao, D. M. F., Yoo, E. K., Macey, W. H., DeNardo, B. J., Bromely, P. G., Geng, Y., Junkins‐Hopkins, J. M., & Lessin, S. R. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640188 · Cited by 133
Functional proteomics of transforming growth factor‐β1‐stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFβ1‐dependent regulation of DNA repair
Kanamoto, T., Hellman, U., Heldin, C., & Souchelnytskyi, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1219 · Cited by 130
HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis
Wei, G., Ku, S., Gene, K. A., Saito, S., Tang, A. A., Zhang, J., Mao, J., Appella, E., Balmain, A., & Huang, E. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703213104 · Cited by 130
Self-citation
Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
Krisanaprakornkit, S., & Iamaroon, A. (2012) · ISRN Oncology · doi:10.5402/2012/681469 · Cited by 134
Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression
Mittapalli, V. R., Madl, J., Löffek, S., Kiritsi, D., Kern, J. S., Römer, W., Nyström, A., & Bruckner‐Tuderman, L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1348 · Cited by 124
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling
Ying, Z., Tian, H., Li, Y., Lian, R., Li, W., Wu, S., Zhang, H., Wu, J., Liu, L., Song, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90439 · Cited by 120
Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines
Rich, J. N., Zhang, M., Datto, M., Bigner, D. D., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35053 · Cited by 120
Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks, B. H., He, W., Olson, K. L., & Wang, X. J. (2001) · PubMed · Cited by 119
Role of the IκB Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells
Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., & Sonenshein, G. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5381-5391.2000 · Cited by 118
TGF-β: A Balancing Act
McCartney-Francis, N. L., Frazier-Jessen, M. R., & Wahl, S. M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043009 · Cited by 117
Smad phospho-isoforms direct context-dependent TGF-β signaling
Matsuzaki, K. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.06.002 · Cited by 115
A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
Bandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells
Azuma, H., Ehata, S., Miyazaki, H., Watabe, T., Maruyama, O., Imamura, T., Sakamoto, T., Kiyama, S., Kiyama, Y., Ubai, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji399 · Cited by 115
Transforming Growth Factor-β Signaling in Epithelial Cells
Hartsough, M. T., & Mulder, K. M. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00020-x · Cited by 112
TGF-β3 and cancer: A review
Laverty, H. G., Wakefield, L. M., Occleston, N. L., O’Kane, S., & Ferguson, M. W. J. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.07.002 · Cited by 110
Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
Lange, C., Gioeli, D., Hammes, S., & Marker, P. C. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160319 · Cited by 122
Roles of Smad3 in TGF-β Signaling During Carcinogenesis
Millet, C., & Zhang, Y. E. (2007) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v17.i4.30 · Cited by 109
Dichotomous roles of TGF-β in human cancer
Huang, J. J., & Blobe, G. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160065 · Cited by 112
Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms
Wang, G., Zhang, M., Cheng, M., Wang, X., Li, K., Chen, J., Chen, Z., Chen, S., Chen, J., Xiong, G., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.009 · Cited by 113
Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis
Wang, Y., Sun, Y., Li, D., Zhang, L., Wang, K., Zuo, Y., Gartner, T. K., & Liu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080780 · Cited by 108
The Role of the TGF-β Coreceptor Endoglin in Cancer
Pérez-Gómez, E., del Castillo, G., Santibanez, J. F., López-Novoa, J. M., Bernabéu, C., & Quintanilla, M. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.230 · Cited by 109
Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development
Guerra, L., Odorisio, T., Zambruno, G., & Castiglia, D. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.01.002 · Cited by 110
It Takes a Tissue to Make a Tumor: Epigenetics, Cancer and the Microenvironment
Barcellos‐Hoff, M. H. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011317009329 · Cited by 106
Healing of Burn Wounds in Transgenic Mice Overexpressing Transforming Growth Factor-β1 in the Epidermis
Yang, L., Chan, T., Demare, J., Iwashina, T., Ghahary, A., Scott, P. G., & Tredget, E. E. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63066-0 · Cited by 105
Smad4 as a Transcription Corepressor for Estrogen Receptor α
Wu, L., Wu, Y., Gathings, B., Wan, M., Li, X., Grizzle, W. E., Liu, Z., Lu, C., Mao, Z., & Cao, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212332200 · Cited by 107
Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa
Tremain, R., Marko, M. G., Vijayachandra, K., Ueno, H., Böttinger, E. P., & Glick, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203471 · Cited by 107
TGFβ signaling in head and neck squamous cell carcinoma
White, R. A., Malkoski, S. P., & Wang, X. (2010) · Oncogene · doi:10.1038/onc.2010.306 · Cited by 104
Androgen Receptor Coregulators in Prostate Cancer
Rahman, M. M., Miyamoto, H., & Chang, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0746-3 · Cited by 103
α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β In vivo , Inhibits Intestinal Tumor Progression
Swallow, C. J., Partridge, E. A., Macmillan, J. C., Tajirian, T., Guglielmo, G. M. D., Hay, K., Szweras, M., Jahnen‐Dechent, W., Wrana, J. L., Redston, M. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1117 · Cited by 102
Overexpression of matrix metalloproteinase‐9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling
Dong, H., Diao, H., Zhao, Y., Xu, H., Pei, S., Gao, J., Wang, J., Hussain, T. A., Zhao, D., Zhou, X., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12633 · Cited by 101
A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon, A. I., Gold, L. I., Wang, J., Cohen, A. M., & Friedman, E. D. (1998) · PubMed · Cited by 100
Transforming growth factor‐β: The breaking open of a black box
Alevizopoulos, A., & Mermod, N. (1997) · BioEssays · doi:10.1002/bies.950190709 · Cited by 99
SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity
Wang, Y., Chu, J., Yi, P., Dong, W., Saultz, J. N., Wang, Y., Wang, H., Scoville, S. D., Zhang, J., Wu, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121227 · Cited by 100
TGFβ and Wnt pathway cross-talk
Attisano, L., & Labbé, E. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025811012690 · Cited by 98
The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability
Yeh, E. S., Lew, B. O., & Means, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505770200 · Cited by 98
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia inSmad4/Dpc4conditional knockout mice
Li, W.-M., Qiao, W., Chen, L., Xu, X., Yang, X. Y., Li, D., Li, C., Brodie, S. G., Meguid, M. M., Hennighausen, L. G., et al. (2003) · Development · doi:10.1242/dev.00820 · Cited by 99
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
Characterization of murine S-endoglin isoform and its effects on tumor development
Pérez-Gómez, E., Eleno, N., López-Novoa, J. M., Ramirez, J. R., Velasco, B., Letarte, M., Bernabéu, C., & Quintanilla, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208644 · Cited by 97
Connective Tissue Growth Factor Gene Expression Alters Tumor Progression in Esophageal Cancer
Koliopanos, A., Friess, H., di Mola, F. F., Tang, W., Kubulus, D., Brigstock, D. R., Zimmermann, A., & Büchler, M. W. (2002) · World Journal of Surgery · doi:10.1007/s00268-001-0242-x · Cited by 96
Regulation of actin organisation by TGF-β in H-ras-transformed fibroblasts
Moustakas, A., & Stournaras, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1169 · Cited by 98
A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation
Mikheev, A. M., Mikheeva, S. A., Liu, B., Cohen, P., & Zarbl, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg190 · Cited by 95
Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis
Piek, E., & Roberts, A. B. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)83001-3 · Cited by 94
Runx3 Protects Gastric Epithelial Cells Against Epithelial-Mesenchymal Transition-Induced Cellular Plasticity and Tumorigenicity
Voon, D. C., Wang, H., Koo, J. K. W., Nguyen, T. A. P., Hor, Y. T., Chu, Y., Ito, K., Fukamachi, H., Chan, S. L., Thiery, J. P., et al. (2012) · Stem Cells · doi:10.1002/stem.1183 · Cited by 93
Conditional epidermal expression of TGFβ1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia
Liu, X. Z., Alexander, V., Vijayachandra, K., Bhogte, E., Diamond, I., & Glick, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161016098 · Cited by 93
Somatic Acquisition and Signaling of TGFBR1 *6A in Cancer
Pasche, B. (2005) · JAMA · doi:10.1001/jama.294.13.1634 · Cited by 92
Targeting the transforming growth factor-β signalling pathway in metastatic cancer
Korpal, M., & Kang, Y. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.040 · Cited by 96
Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition
Lamouille, S., & Derynck, R. (2010) · Cells Tissues Organs · doi:10.1159/000320172 · Cited by 96
Developmentally regulated signaling pathways in glioma invasion
Mehta, S. V., & Cascio, C. L. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2608-8 · Cited by 93
TGFβ/Smad signaling system and its pathologic correlates
Cohen, M. M. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10750 · Cited by 91
TGF-β, Neuronal Stem Cells and Glioblastoma
Golestaneh, N., & Mishra, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208925 · Cited by 90
Oncogenic resistance to growth-limiting conditions
Blagosklonny, M. V. (2002) · Nature reviews. Cancer · doi:10.1038/nrc743 · Cited by 92
Carcinogenesis, cancer therapy and chemoprevention
Blagosklonny, M. V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401610 · Cited by 90

Authors: Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J.
Affiliations: University of Glasgow (GB)
Corresponding author: Akhurst, Rosemary J
ORCID: Cui, Wei
Bryson, Sheila
Balmain, Allan
Akhurst, Rosemary J
Venue: Cell
Publisher: Elsevier BV
Published: 1996-08
Volume: 86
Issue: 4
Pages: 531-542
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)80127-0
OpenAlex: W2026460094
Cited by: 628
References: 98
Citations by year: 2026: 6 · 2025: 4 · 2024: 10 · 2023: 20 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 15 · 2014: 22 · 2013: 22 · 2012: 26
FWCI: 7.57
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6194 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
Keywords: TGF-β1, skin carcinogenesis, sarcomatoid carcinoma, keratinocytes, tumor suppressor, malignant progression, TGF-beta3, epithelial-mesenchymal transition, chemical carcinogenesis, transgenic mice, epithelial cell plasticity
MeSH terms: Animals, Carcinoma, Carcinoma, Squamous Cell, Cells, Cultured, Female, Immunologic Techniques, Keratins, Mice, Transgenic, Papilloma, Skin Neoplasms, Integrins, Transforming Growth Factor beta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks